Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women.

Mnqonywa N, Abbai N, Ragupathy V, Ramjee G, Hewlett I, Moodley D.

BMC Res Notes. 2019 Nov 15;12(1):745. doi: 10.1186/s13104-019-4785-z.

2.

Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.

Daniels B, Coutsoudis A, Moodley-Govender E, Mulol H, Spooner E, Kiepiela P, Reddy S, Zako L, Ho NT, Kuhn L, Ramjee G.

Lancet Glob Health. 2019 Dec;7(12):e1717-e1727. doi: 10.1016/S2214-109X(19)30422-X.

3.

Linkage to Care Following an HIV Diagnosis in Three Public Sector Clinics in eThekwini (Durban), South Africa: Findings from a Prospective Cohort Study.

Hoffman S, Leu CS, Ramjee G, Blanchard K, Gandhi AD, O'Sullivan L, Kelvin EA, Exner TM, Mantell JE, Lince-Deroche N.

AIDS Behav. 2019 Nov 1. doi: 10.1007/s10461-019-02688-1. [Epub ahead of print]

PMID:
31677039
4.

Evaluation of a health system intervention to improve virological management in an antiretroviral programme at a municipal clinic in central Durban.

Cloete CM, Hampton J, Chetty T, Ngomane T, Spooner E, Zako LMG, Reddy S, Reddy T, Luthuli N, Ngobese H, Ramjee G, Coutsoudis A, Kiepiela P.

South Afr J HIV Med. 2019 Sep 26;20(1):985. doi: 10.4102/sajhivmed.v20i1.985. eCollection 2019.

5.

Investigating spatial disparities in high-risk women and HIV infections using generalized additive models: Results from a cohort of South African women.

Wand H, Reddy T, Ramjee G.

Spat Spatiotemporal Epidemiol. 2019 Aug;30:100283. doi: 10.1016/j.sste.2019.100283. Epub 2019 May 29.

PMID:
31421797
6.

Point-of-care HIV testing best practice for early infant diagnosis: an implementation study.

Spooner E, Govender K, Reddy T, Ramjee G, Mbadi N, Singh S, Coutsoudis A.

BMC Public Health. 2019 Jun 11;19(1):731. doi: 10.1186/s12889-019-6990-z.

7.

A decade of sustained geographic spread of HIV infections among women in Durban, South Africa.

Ramjee G, Sartorius B, Morris N, Wand H, Reddy T, Yssel JD, Tanser F.

BMC Infect Dis. 2019 Jun 7;19(1):500. doi: 10.1186/s12879-019-4080-6.

8.

Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis.

Chimukangara B, Lessells RJ, Rhee SY, Giandhari J, Kharsany ABM, Naidoo K, Lewis L, Cawood C, Khanyile D, Ayalew KA, Diallo K, Samuel R, Hunt G, Vandormael A, Stray-Pedersen B, Gordon M, Makadzange T, Kiepiela P, Ramjee G, Ledwaba J, Kalimashe M, Morris L, Parikh UM, Mellors JW, Shafer RW, Katzenstein D, Moodley P, Gupta RK, Pillay D, Abdool Karim SS, de Oliveira T.

EClinicalMedicine. 2019 Mar 18;9:26-34. doi: 10.1016/j.eclinm.2019.03.006. eCollection 2019 Mar.

9.

Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.

Boodhram R, Moodley D, Abbai N, Ramjee G.

BMC Womens Health. 2019 May 8;19(1):63. doi: 10.1186/s12905-019-0761-y.

10.

Correlates of Sexually Transmitted Infections Among South African Women Using Individual- and Community-Level Factors: Results from Generalized Additive Mixed Models.

Wand H, Morris N, Dassaye R, Reddy T, Ramjee G.

Arch Sex Behav. 2019 Feb 14. doi: 10.1007/s10508-018-1315-3. [Epub ahead of print]

PMID:
30767180
11.

Geographical-level contributions of risk factors for HIV infections using generalized additive models: results from a cohort of South African women.

Wand H, Dassaye R, Reddy T, Yssel J, Ramjee G.

AIDS Care. 2019 Jun;31(6):714-722. doi: 10.1080/09540121.2018.1556382. Epub 2018 Dec 11.

PMID:
30537858
12.

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring.

Riddler SA, Balkus JE, Parikh UM, Mellors JW, Akello C, Dadabhai S, Mhlanga F, Ramjee G, Mayo AJ, Livant E, Heaps AL, O'Rourke C, Baeten JM; MTN-015; MTN-020/ASPIRE Study Teams.

Clin Infect Dis. 2018 Oct 22. doi: 10.1093/cid/ciy909. [Epub ahead of print]

13.

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters.

Gossez M, Martin GE, Pace M, Ramjee G, Premraj A, Kaleebu P, Rees H, Inshaw J, Stöhr W, Meyerowitz J, Hopkins E, Jones M, Hurst J, Porter K, Babiker A, Fidler S, Frater J; SPARTAC Trial Investigators.

AIDS. 2019 Feb 1;33(2):185-197. doi: 10.1097/QAD.0000000000002044.

14.

Targeted Pregnancy and Human Immunodeficiency Virus Prevention Risk-Reduction Counseling for Young Women: Lessons Learned from Biomedical Prevention Trials.

Ramjee G, Dassaye R, Reddy T, Wand H.

J Infect Dis. 2018 Oct 20;218(11):1759-1766. doi: 10.1093/infdis/jiy388.

15.

Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.

Nel A, Martins J, Bekker LG, Ramjee G, Masenga G, Rees H, van Niekerk N.

PLoS One. 2018 May 29;13(5):e0196904. doi: 10.1371/journal.pone.0196904. eCollection 2018.

16.

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.

Martin GE, Pace M, Thornhill JP, Phetsouphanh C, Meyerowitz J, Gossez M, Brown H, Olejniczak N, Lwanga J, Ramjee G, Kaleebu P, Porter K, Willberg CB, Klenerman P, Nwokolo N, Fox J, Fidler S, Frater J.

Front Immunol. 2018 May 4;9:928. doi: 10.3389/fimmu.2018.00928. eCollection 2018.

17.

Social Support and Violence-prone Relationships as Predictors of Disclosure of HIV Status Among Newly Diagnosed HIV-positive South Africans.

Fifield J, O'Sullivan L, Kelvin EA, Mantell JE, Exner T, Ramjee G, Blanchard K, Hoffman S.

AIDS Behav. 2018 Oct;22(10):3287-3295. doi: 10.1007/s10461-018-2136-z.

18.

Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Janes H, Corey L, Ramjee G, Carpp LN, Lombard C, Cohen MS, Gilbert PB, Gray GE.

AIDS Res Hum Retroviruses. 2018 Aug;34(8):645-656. doi: 10.1089/AID.2018.0031. Epub 2018 Jun 19. Review.

19.
20.

Study protocol for a longitudinal study evaluating the impact of rape on women's health and their use of health services in South Africa.

Abrahams N, Seedat S, Lombard C, Kengne AP, Myers B, Sewnath A, Mhlongo S, Ramjee G, Peer N, Garcia-Moreno C, Jewkes R.

BMJ Open. 2017 Sep 29;7(9):e017296. doi: 10.1136/bmjopen-2017-017296.

21.

Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa.

Abbai NS, Nyirenda M, Naidoo S, Ramjee G.

AIDS Behav. 2018 Jul;22(7):2172-2180. doi: 10.1007/s10461-017-1924-1.

22.

Detecting Mycobacterium tuberculosis using the loop-mediated isothermal amplification test in South Africa.

Reddy S, Ntoyanto S, Sakadavan Y, Reddy T, Mahomed S, Dlamini M, Spooner B, Ramjee G, Coutsoudis A, Ngomane N, Naidoo K, Mlisana K, Kiepiela P.

Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1154-1160. doi: 10.5588/ijtld.16.0863.

PMID:
28911361
23.

"I did not see a need to get tested before, everything was going well with my health": a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa.

Tariq S, Hoffman S, Ramjee G, Mantell JE, Phillip JL, Blanchard K, Lince-Deroche N, Exner TM.

AIDS Care. 2018 Jan;30(1):32-39. doi: 10.1080/09540121.2017.1349277. Epub 2017 Jul 11.

24.

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.

Riddler SA, Husnik M, Ramjee G, Premrajh A, Tutshana BO, Pather A, Siva S, Jeenarain N, Nair G, Selepe P, Kabwigu S, Palanee-Phillips T, Panchia R, Mhlanga F, Levy L, Livant E, Patterson K, Elharrar V, Balkus J.

PLoS One. 2017 Jun 28;12(6):e0178594. doi: 10.1371/journal.pone.0178594. eCollection 2017.

25.

A Simple Risk Prediction Algorithm for HIV Transmission: Results from HIV Prevention Trials in KwaZulu Natal, South Africa (2002-2012).

Wand H, Reddy T, Naidoo S, Moonsamy S, Siva S, Morar NS, Ramjee G.

AIDS Behav. 2018 Jan;22(1):325-336. doi: 10.1007/s10461-017-1785-7.

PMID:
28470458
27.

Erratum to: Sharing of Investigational Drug Among Participants in the Voice Trial.

Moodley J, Naidoo S, Moodley J, Ramjee G.

AIDS Behav. 2016 Nov;20(11):2715-2716. No abstract available.

PMID:
27246279
28.

Sharing of Investigational Drug Among Participants in the Voice Trial.

Moodley J, Naidoo S, Moodley J, Ramjee G.

AIDS Behav. 2016 Nov;20(11):2709-2714. Erratum in: AIDS Behav. 2016 Nov;20(11):2715-2716.

29.

Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.

Friedland BA, Stoner M, Chau MM, Plagianos MG, Govender S, Morar N, Altini L, Skoler-Karpoff S, Ahmed K, Ramjee G, Monedi C, Maguire R, Lähteenmäki P.

AIDS Behav. 2016 Nov;20(11):2565-2577.

30.

Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care.

Hoffman S, Exner TM, Lince-Deroche N, Leu CS, Phillip JL, Kelvin EA, Gandhi AD, Levin B, Singh D, Mantell JE, Blanchard K, Ramjee G.

PLoS One. 2016 Oct 5;11(10):e0162085. doi: 10.1371/journal.pone.0162085. eCollection 2016.

31.

Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.

Coutsoudis A, Daniels B, Moodley-Govender E, Ngomane N, Zako L, Spooner E, Kiepiela P, Reddy S, Kuhn L, Ramjee G.

BMJ Open. 2016 Jul 12;6(7):e010656. doi: 10.1136/bmjopen-2015-010656.

32.
33.

Research participants' skills development as HIV prevention peer educators in their communities.

Morar NS, Naidoo S, Goolam A, Ramjee G.

J Health Psychol. 2018 Sep;23(10):1343-1349. doi: 10.1177/1359105316655470. Epub 2016 Jun 30.

PMID:
27371447
34.

PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa.

Skhosana M, Reddy S, Reddy T, Ntoyanto S, Spooner E, Ramjee G, Ngomane N, Coutsoudis A, Kiepiela P.

South Afr J HIV Med. 2016 Jun 24;17(1):444. doi: 10.4102/sajhivmed.v17i1.444. eCollection 2016.

35.

Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study.

Kasaro MP, Husnik MJ, Chi BH, Reid C, Magure T, Makanani B, Tembo T, Ramjee G, Maslankowski L, Rabe L, Brad Guffey M.

Int J STD AIDS. 2017 Apr;28(5):467-475. doi: 10.1177/0956462416653001. Epub 2016 Jul 10.

36.

Poor Performance of the Chlamydia Rapid Test Device for the Detection of Asymptomatic Infections in South African Men: A Pilot Study.

Abbai-Shaik NS, Reddy T, Govender S, Ramjee G.

J Sex Transm Dis. 2016;2016:8695146. doi: 10.1155/2016/8695146. Epub 2016 Apr 19.

37.

Individual and Population Level Impact of Key HIV Risk Factors on HIV Incidence Rates in Durban, South Africa.

Ramjee G, Moonsamy S, Abbai NS, Wand H.

PLoS One. 2016 Apr 22;11(4):e0153969. doi: 10.1371/journal.pone.0153969. eCollection 2016.

38.

Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31].

Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM.

Contraception. 2016 Jul;94(1):95. doi: 10.1016/j.contraception.2016.03.018. Epub 2016 Apr 14. No abstract available.

PMID:
27085419
39.

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.

Thornhill J, Inshaw J, Kaleebu P, Cooper D, Ramjee G, Schechter M, Tambussi G, Fox J, Samuel M, Miro JM, Weber J, Porter K, Fidler S.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):69-73. doi: 10.1097/QAI.0000000000001013.

40.

Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban.

Abbai NS, Wand H, Ramjee G.

BMC Womens Health. 2016 Mar 19;16:19. doi: 10.1186/s12905-016-0295-5.

41.

Predictors of perceived male partner concurrency among women at risk for HIV and STI acquisition in Durban, South Africa.

Gaffoor Z, Wand H, Street RA, Abbai N, Ramjee G.

AIDS Res Ther. 2016 Mar 8;13:14. doi: 10.1186/s12981-016-0098-7. eCollection 2016.

42.

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.

Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S; MTN-020–ASPIRE Study Team.

N Engl J Med. 2016 Dec 1;375(22):2121-2132. Epub 2016 Feb 22.

43.

The role of progestins in HIV acquisition in young women.

Ramjee G, McCormack S.

Lancet Infect Dis. 2016 Apr;16(4):389-90. doi: 10.1016/S1473-3099(15)00476-4. Epub 2015 Dec 24. No abstract available.

PMID:
26723757
45.

Prevalent bacterial vaginosis infection - a risk factor for incident sexually transmitted infections in women in Durban, South Africa.

Abbai NS, Reddy T, Ramjee G.

Int J STD AIDS. 2016 Dec;27(14):1283-1288. Epub 2015 Nov 3.

PMID:
26538552
46.

Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.

Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM.

Contraception. 2016 Jan;93(1):25-31. doi: 10.1016/j.contraception.2015.10.010. Epub 2015 Oct 28.

47.

Contraception use and impact on pregnancy prevention in women participating in an HIV prevention trial in South Africa.

Moodley J, Naidoo S, Wand H, Ramjee G; Microbicides Development Programme team.

J Fam Plann Reprod Health Care. 2016 Jan;42(1):5-11. doi: 10.1136/jfprhc-2014-101100. Epub 2015 Aug 10.

48.

Towards host-directed therapies for tuberculosis.

Zumla A, Maeurer M; Host-Directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS.

Nat Rev Drug Discov. 2015 Aug;14(8):511-2. doi: 10.1038/nrd4696. Epub 2015 Jul 17.

PMID:
26184493
49.

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.

Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM; VOICE Study Team.

Lancet HIV. 2015 Jul;2(7):e279-87.

50.

The generational effect on age disparate partnerships and the risk for human immunodeficiency virus and sexually transmitted infections acquisition.

Street RA, Reddy T, Ramjee G.

Int J STD AIDS. 2016 Aug;27(9):746-52. doi: 10.1177/0956462415592325. Epub 2015 Jul 2.

PMID:
26138899

Supplemental Content

Loading ...
Support Center